Ani Pharmaceuticals Inc (ANIP)
EBITDA Margin
22.69%
Quarterly · Period ending:
ANIP EBITDA Margin
Latest reported22.69%period ending
Latest reported22.69%period ending
ANIP Quarterly EBITDA Margin (0.00% → 22.69%)
Quarterly ebitda margin
High-resolution chart · PNG
ANIP ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 22.6929% | |
| 24.1601% | |
| 31.139% | |
| 26.8461% | |
| 18.5664% | |
| 24.534% | |
| 7.7938% | |
| -9.0466% | |
| 12.3631% | |
| 32.4682% | |
| 16.6246% | |
| 25.1204% | |
| 23.2001% | |
| 23.0002% | |
| 18.412% | |
| 12.3978% | |
| 2.7419% | |
| -7.3313% | |
| -20.8915% | |
| 12.8945% | |
| -8.835% | |
| 24.629% | |
| 19.3373% | |
| 26.2953% | |
| -0.4642% | |
| 6.7324% | |
| 9.9696% | |
| 32.7269% | |
| 34.6046% | |
| 38.5255% | |
| 34.4036% | |
| 36.8459% | |
| 32.8891% | |
| 31.5621% | |
| 30.4488% | |
| 34.3099% | |
| 31.4449% | |
| 30.8862% | |
| 18.4976% | |
| 35.9922% | |
| 39.7294% | |
| 49.9878% | |
| 46.4597% | |
| 52.5636% | |
| 50.3638% | |
| 57.9499% | |
| 57.299% | |
| 53.9829% | |
| -26.3878% | |
| 38.5173% | |
| 37.0032% | |
| 15.2114% | |
| -27.25% | |
| -1,420.0165% | |
| 1.2896% | |
| -5,572.1914% | |
| -6,654.2747% | |
| -8,867.9079% | |
| -7,309.9866% | |
| -6,852.9089% | |
| -16,078.9391% | |
| -29,889.0035% | |
| -9,179.3403% | |
| -21,817.5703% | |
| 0% | |
| -390.9864% | |
| -2,192.7894% | |
| -46,385.6367% | |
| -3,983.3705% | |
| -5,893.8066% | |
| -51.2385% | |
| -8,124.2106% | |
| -21,266.3999% | |
| -8,680.0491% | |
| -608.3185% | |
| -4,861.8843% | |
| -3,747.0797% | |
| -3,666.6752% | |
| 70.9451% | |
| -596.3485% | |
| -1,294.1147% | |
| -3,893.7836% | |
| -1,823.408% | |
| -2,218.1514% | |
| -5,828.292% | |
| -9,915.6014% | |
| -7,629.543% | |
| -27,207.034% | |
| -52,331.5314% | |
| -33,477.556% | |
| 3,093.7244% | |
| -5,574.5462% | |
| 0% | |
| -1,448.333% | |
| -21.064% | |
| -80.8061% | |
| 0% | |
| 0% | |
| 78.8417% | |
| 1.228% |